External Defibrillators - Day 1 The Food and Drug Administration (FDA) is holding a public workshop to share FDA’s understanding of the risks and benefits of external defibrillators, to clarify FDA’s current expectations for how industry should identify, report, and take action on problems observed with these devices, and to promote innovation for next-generation devices that will bring safer, more effective external defibrillators to market. (Javascript is required to view Mediasite content)